|
Lipoic acid (DL, α)
- 英文名称：Lipoic acid (DL, α)
- 品牌：WYTSCI
- 产地：进口
- 型号：1MG
- 货号：WT-AY-B11506
- cas：1077-28-7
- 价格： ￥1/mg
- 发布日期： 2025-04-10
- 更新日期： 2025-10-24
产品详请
| 产地 | 进口 |
| 品牌 | WYTSCI |
| 货号 | WT-AY-B11506 |
| 用途 | 科研检测 |
| 英文名称 | Lipoic acid (DL, α) |
| 包装规格 | 1MG |
| CAS编号 | 1077-28-7 |
| 别名 | Lipoic acid (DL, α) |
| 纯度 | 98+% |
| 分子式 | |
| 是否进口 | 是 |
纯度:>98% by TLC;NMR (Conforms)
分子式:C8H14O2S2
分子量:206.32
溶剂:DMSO (30 mg/ml)
性状:Pale-yellow solid
存储:-20°C
Activity (short version):Endogenous antioxidant and cofactor
Function / Pharmacology:Endogenous antioxidant.1,2 Treatment with alpha-lipoic acid increased hepatic nuclear Nrf2 levels, induced Nrf2-mediated gene transcription, and reversed age-related decline in hepatic glutathione levels in a rat model.3 It is an essential cofactor required for catalysis by multiple mitochondrial enzymes including pyruvate dehydrogenase, α-ketoglutarate dehydrogenase and branched-chain ketoacid dehydrogenase among others.4 It has shown efficacy as a treatment in diabetic neuropathy.5
分子式:C8H14O2S2
分子量:206.32
溶剂:DMSO (30 mg/ml)
性状:Pale-yellow solid
存储:-20°C
Activity (short version):Endogenous antioxidant and cofactor
Function / Pharmacology:Endogenous antioxidant.1,2 Treatment with alpha-lipoic acid increased hepatic nuclear Nrf2 levels, induced Nrf2-mediated gene transcription, and reversed age-related decline in hepatic glutathione levels in a rat model.3 It is an essential cofactor required for catalysis by multiple mitochondrial enzymes including pyruvate dehydrogenase, α-ketoglutarate dehydrogenase and branched-chain ketoacid dehydrogenase among others.4 It has shown efficacy as a treatment in diabetic neuropathy.5
